Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Cerebral edema commonly accompanies brain tumors and contributes to neurologic symptoms. The role of the interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles (SPION–IL-1Ra) was assessed to analyze its anti-edemal effect and its possible application as a negativ...

Full description

Bibliographic Details
Main Authors: Maxim A. Shevtsov, Boris P. Nikolaev, Ludmila Y. Yakovleva, Anatolii V. Dobrodumov, Alexander V. Zhakhov, Anastasiy L. Mikhrina, Emil Pitkin, Marina A. Parr, Valerii I. Rolich, Andrei S. Simbircev, Alexander M. Ischenko
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558614001663

Internet

http://www.sciencedirect.com/science/article/pii/S1476558614001663

Similar Items